JOHNSON KENNETH ERLAND (See Remarks) received a stock award from XERIS PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/15/2020ACC: 0000899243-20-019177
Officer· See Remarks
Since Jan 2019
+775.00
Net shares
Net buyer
$1.8K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
775.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+775.00
Price / share
$2.26
Trade value
$1.75K
% of position
3.0%
6/30/2020
26.11K→26.89K
Total
Net shares
+775.00
Net value
$1.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2020 | A · Award | +775.00 | $2.26 | $1.75K | 3.0% | 26.11K | 26.89K |
| Total | +775.00 | $1.75K | ||||||
Derivative Transactions0
No derivative transactions reported